Exencial Wealth Advisors, LLC Novartis Ag Transaction History
Exencial Wealth Advisors, LLC
- $2.75 Billion
- Q2 2025
A detailed history of Exencial Wealth Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Exencial Wealth Advisors, LLC holds 98,416 shares of NVS stock, worth $11.7 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
98,416
Previous 118,019
16.61%
Holding current value
$11.7 Million
Previous $13.2 Million
9.48%
% of portfolio
0.43%
Previous 0.5%
Shares
32 transactions
Others Institutions Holding NVS
# of Institutions
1,552Shares Held
142MCall Options Held
1.64MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.41 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.24 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.08 Billion0.26% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$850 Million0.35% of portfolio
-
Morgan Stanley New York, NY7.06MShares$842 Million0.06% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $257B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...